Category: Company News

RF Industries posted record third-quarter fiscal 2026 net sales of nearly $24 million, alongside higher margins, net income and adjusted EBITDA as bookings supported a $19.8 million current backlog. Key Investor Takeaways Why RFIL Stock Is in Focus RF Industries’ record Q3 fiscal 2026 sales were accompanied by improvement across several profitability measures, providing investors…

Hain Celestial reported lower fiscal 2026 sales and adjusted EBITDA, while fourth-quarter North America organic growth, margin expansion and stronger free cash flow highlighted progress ahead of the planned sale of its International business. Key Investor Takeaways Why HAIN Stock Is in Focus Hain Celestial’s fiscal 2026 results showed a business that became smaller following…

The acquisition would give Revolve its first operating U.S. power project, with US$7.25 million of project-level debt financing secured from EDC and Vancity. Key Investor Takeaways Why REVVF Stock Is in Focus Revolve has signed definitive agreements to acquire the Horseshoe Bend Wind Project for US$10.48 million, marking a planned entry into operating renewable power…

The Mikkeli project is being engineered for future NVIDIA Vera Rubin requirements while initial HGX and MGX clusters are intended to support nearer-term AI training and inference workloads. Key Investor Takeaways Why MASK Stock Is in Focus 3 E Network has detailed how it intends to build the physical infrastructure of its Mikkeli AI data…

American Fusion says its Texatron program is targeting unity or beyond-unity testing by the end of 2026, while prospective commercial opportunities remain dependent on successful validation. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion provided additional details about its Texatron testing and commercialization strategy through an interview with Executive Chairman Brent Nelson.…

Black Dragon Resource says its chairman and CEO is committing funds without convertible notes or toxic investments as the company targets share retirement, an acquisition and an upgrade to a higher trading tier. Key Investor Takeaways Why BDGR Stock Is in Focus Black Dragon Resource announced a financial commitment from its chairman and CEO aimed…

The first overseas purchase of AeroVironment’s LOCUST laser weapon system expands the directed energy platform beyond its U.S. deployments and follows a $464.8 million U.S. Army contract. Key Investor Takeaways Why AVAV Stock Is in Focus AeroVironment has secured its first international LOCUST counter-drone system order, moving the high-energy laser platform into an overseas commercial…

The completed SKNJCT-003 study is shaping Medicus Pharma’s next clinical strategy, with the 200 µg dose moving into an FDA-authorized Gorlin syndrome program while the company considers partnerships for nodular basal cell carcinoma. Key Investor Takeaways Why MDCX Stock Is in Focus Medicus Pharma has published an abridged final Clinical Study Report for its Phase…

Fiscal 2026 revenue fell 10.8% to $1.50 billion and adjusted EBITDA declined to $2.9 million, while the company amended its credit agreement and began reviewing financing and asset-sale alternatives. Key Investor Takeaways Why FLWS Stock Is in Focus 1-800-FLOWERS.COM reported lower fiscal 2026 revenue and adjusted profitability while outlining measures intended to provide additional financial…

The FDA is expected to decide by January 10, 2027, after a Phase III study showed Enspryng reduced the risk of MOGAD relapse by 68% versus placebo. Key Investor Takeaways Why RHHBY Stock Is in Focus The FDA granted Priority Review to Genentech’s application seeking to expand Enspryng into myelin oligodendrocyte glycoprotein antibody-associated disease, or…